About George Kong
Dr George Kong is a comprehensive ophthalmologist and Glaucoma subspecialist with a particular interest in cataract surgery, comprehensive glaucoma management, minimally invasive glaucoma surgery, and complex glaucoma caused by angle closure and inflammatory eye diseases.
Dr Kong completed VCE in Melbourne finishing top of the state of Victoria in Mathematics. He then completed his medical degree (MBBS) from The University of Melbourne, Australia. He successfully completed his PhD in 2011 supported by National Health and Medical Research Council Postgraduate Training Scholarship. He was awarded the prestigious EberhardDodt Memorial Award from the International Society for Clinical Electrophysiology of Vision (ISCEV) for his work on retinal electrophysiology.
Dr Kong completed RANZCO (Royal Australian and New Zealand College of Ophthalmologists) accredited training at the Royal Victorian Eye and Ear Hospital. Subsequently, he embarked on a subspecialty Glaucoma fellowship at The Royal Victorian Eye and Ear Hospital where he gained medical and surgical expertise in the treatment of glaucoma. He then traveled to Cambridge, United Kingdom, where he gained expertise in the advanced management of complex cataract and glaucoma conditions such as glaucoma caused by inflammatory eye diseases (uveitis) and children’s glaucoma. He has also trained in laser procedures for glaucoma and in new surgical techniques of Minimally Invasive Glaucoma Surgery.
Dr Kong published over 40 international peer-reviewed journals, 2 book chapters and is a reviewer of several ophthalmology and optometry journals. He was instrumental in the development of the GONE (Glaucoma Optic Neuropathy Evaluation) website which has helped thousands of optometrists and junior ophthalmologists around the world improve their optic nerve examination techniques. He is a co-inventor of software for visual field testing software on iPad – Melbourne Rapid Fields. Dr Kong received research funding from Ophthalmic Research Institute of Australia to conduct visual field home monitoring trial.